Physician profile
Timothy James Doig
NPI 1861705402
$18,270.01
in general payments reported to CMS, 2019-2025
25 companies · $2,886 in 2025
The $2,886 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,098 · 2020: $198 · 2021: $2,655 · 2022: $3,042 · 2023: $2,186 · 2024: $1,205 · 2025: $2,886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,677 · Travel and Lodging: $2,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,676.77 |
| Travel and Lodging | $2,600.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $7,269.59 | 2019-2025 | |
| Stryker Corporation | $4,144.96 | 2019-2025 | Mako, Triathlon, Insignia |
| Arthrex, INC. | $2,973.40 | 2019-2025 | |
| Depuy Synthes Sales INC. | $921.42 | 2019-2025 | Na, Va-Lcp, Fibulink |
| Djo, LLC | $532.87 | 2019-2024 | Donjoy, Aircast |
| Zimmer Biomet Holdings, INC. | $310.59 | 2019-2025 | Juggerstitch, Tapestry |
| Inari Medical, INC. | $304.15 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Smith+Nephew, INC. | $268.28 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Sanara Medtech INC. | $207.52 | 2024-2025 | Celleraterx, Biasurge |
| Heron Therapeutics, INC. | $158.10 | 2022 | |
| Linvatec Corporation | $147.13 | 2024 | Biobrace 23mm |
| Maxx Orthopedics, INC. | $127.10 | 2024 | |
| Heraeus Medical, LLC. | $119.16 | 2024 | |
| Pacira Therapeutics, INC. | $106.92 | 2019 | |
| Kci USA, INC. | $100.00 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $93.33 | 2021 | |
| Bioventus LLC | $84.27 | 2019-2025 | Xcell, Durolane |
| Ortho Development Corporation | $74.64 | 2021 | |
| Kerecis Limited | $69.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Baxter Healthcare | $57.42 | 2019-2020 | |
| Uoc USA INC | $56.72 | 2022 | |
| Vericel Corporation | $56.40 | 2022-2025 | Maci |
| Ethicon US, LLC | $40.28 | 2022-2024 | Stratafix, Dermabond Prineo, Ethicon |
| Pacira Pharmaceuticals Incorporated | $33.62 | 2023-2024 | Iovera, Exparel, Zilretta |
| Ferring Pharmaceuticals INC. | $13.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Doig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.